Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Rental sales in the Health and Lifestyle Services segment remained strong, while prescription prices per prescription in the Pharmacy Services segment increased due to the growth in long-term prescriptions and prescriptions for high-priced pharmaceuticals, among other factors. Profit benefited from the increase in revenue in Health and Lifestyle Services, improved turnover of rental supplies, improved profitability in the food services business, lower rental supply costs in Environmental Services, and the absence of the initial costs incurred in the previous year.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥40,582 million (YoY +3.6%) |
| Operating profit | ¥2,072 million (YoY +11.5%) |
| Ordinary income | ¥2,244 million (YoY +10.1%) |
| Profit attributable to owners of the parent | ¥1,438 million (YoY +7.2%) |
| Net income per share | ¥46.57 |
| Equity ratio | End of the current fiscal period 72.5 / End of previous period 73 |
| Total assets | ¥116,600 million |
| Net assets | ¥85,315 million |
| Full-year earnings forecast | Net Sales ¥165,400 million (YoY +3.6%) / Operating profit ¥8,985 million (YoY -4.2%) / Ordinary income ¥9,437 million (YoY -6.5%) / Profit attributable to owners of the parent ¥6,117 million (YoY +0.8%) |
| Annual Dividend Forecast | ¥68 → ¥80 |
| Segment revenue | Healthy Living Services ¥21,187 million (YoY +4.6%), Pharmacy services ¥15,678 million (YoY +3.3%), Environmental Services ¥3,684 million (YoY -0.4%) |
| Segment profit | Healthy Living Services ¥2,043 million (YoY +11.2%), Pharmacy services ¥299 million (YoY -13.4%), Environmental Services ¥421 million (YoY +35.6%) |
| Depreciation and amortization | ¥1,098 million |
| Impairment loss | No material items to report |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥22 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥4 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 株式会社日晴リネンサプライ / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | All shares of QLCプロデュース株式会社 were acquired on 31 July 2026, making it a subsidiary. The purchase consideration was ¥2,910 million in cash, and the voting rights acquired amounted to 100%. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 33,092,146 |
| Treasury Shares at Period-End | 2,207,536 |
| Factors Behind Changes in Business Performance | Rental sales in the Health and Lifestyle Services segment remained strong, while prescription prices per prescription in the Pharmacy Services segment increased due to the growth in long-term prescriptions and prescriptions for high-priced pharmaceuticals, among other factors. Profit benefited from the increase in revenue in Health and Lifestyle Services, improved turnover of rental supplies, improved profitability in the food services business, lower rental supply costs in Environmental Services, and the absence of the initial costs incurred in the previous year. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Rental sales in the Health and Lifestyle Services segment remained strong, while sales in the Pharmacy Services segment increased as a result of higher prescription prices per prescription. In terms of profit, the benefits of ongoing earnings improvement measures, primarily in Health and Lifestyle Services, continued, while the impact of the temporary increase in expenses incurred in the Environmental Services segment in the same period of the previous year diminished.